Back to Search
Start Over
Supplementary Data from ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8c040166ba1f157e501dc8a4975a1585